Lorrain Daniel S. Insider Trades

Insider Trading History

Track insider trading activity for Lorrain Daniel S.. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Contineum Therapeutics
Contineum Therapeutics CTNM
Chief Scientific Officer
Holding Value $1.78M 143,842 shares
Last Trade
May 01, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$54.7k 4,170 shares
$13.12
$12.34
Contineum Therapeutics
Contineum Therapeutics CTNM
Chief Scientific Officer
Holding Value $1.82M 147,712 shares
Last Trade
Apr 06, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$56k 4,170 shares
$13.43
$12.34
Contineum Therapeutics
Contineum Therapeutics CTNM
Chief Scientific Officer
Holding Value $1.87M 151,882 shares
Last Trade
Mar 02, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$62.6k 4,170 shares
$15.01
$12.34
Contineum Therapeutics
Contineum Therapeutics CTNM
Chief Scientific Officer
Holding Value $1.97M 159,876 shares
Last Trade
Feb 25, 2026 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$60.3k 3,824 shares
$15.78
$12.34
Contineum Therapeutics
Contineum Therapeutics CTNM
Chief Scientific Officer
Holding Value $831k 67,306 shares
Last Trade
Feb 25, 2026 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$60.3k 3,824 shares
$15.78
$12.34
Contineum Therapeutics
Contineum Therapeutics CTNM
Chief Scientific Officer
Holding Value $1.93M 156,052 shares
Last Trade
Feb 25, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$61.2k 3,824 shares
$16.01
$12.34
Contineum Therapeutics
Contineum Therapeutics CTNM
Chief Scientific Officer
Holding Value $1.98M 160,352 shares
Last Trade
Feb 24, 2026 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$68.5k 4,300 shares
$15.93
$12.34
Contineum Therapeutics
Contineum Therapeutics CTNM
Chief Scientific Officer
Holding Value $1.93M 156,052 shares
Last Trade
Feb 24, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$68.9k 4,300 shares
$16.03
$12.34
Contineum Therapeutics
Contineum Therapeutics CTNM
Chief Scientific Officer
Holding Value $878k 71,130 shares
Last Trade
Feb 24, 2026 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$68.5k 4,300 shares
$15.93
$12.34
Contineum Therapeutics
Contineum Therapeutics CTNM
Chief Scientific Officer
Holding Value $1.93M 156,052 shares
Last Trade
Feb 19, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$1.6k 100 shares
$16.00
$12.34
Contineum Therapeutics
Contineum Therapeutics CTNM
Chief Scientific Officer
Holding Value $931k 75,430 shares
Last Trade
Feb 19, 2026 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$1.6k 100 shares
$16.00
$12.34
Contineum Therapeutics
Contineum Therapeutics CTNM
Chief Scientific Officer
Holding Value $1.93M 156,152 shares
Last Trade
Feb 19, 2026 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$1.6k 100 shares
$16.00
$12.34
Contineum Therapeutics
Contineum Therapeutics CTNM
Chief Scientific Officer
Holding Value $1.93M 156,052 shares
Last Trade
Feb 11, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$6.4k 400 shares
$16.00
$12.34
Contineum Therapeutics
Contineum Therapeutics CTNM
Chief Scientific Officer
Holding Value $932k 75,530 shares
Last Trade
Feb 11, 2026 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$6.1k 400 shares
$15.26
$12.34
Contineum Therapeutics
Contineum Therapeutics CTNM
Chief Scientific Officer
Holding Value $1.93M 156,452 shares
Last Trade
Feb 11, 2026 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$6.1k 400 shares
$15.26
$12.34
Contineum Therapeutics
Contineum Therapeutics CTNM
Chief Scientific Officer
Holding Value $1.94M 157,222 shares
Last Trade
Feb 03, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$62.3k 4,170 shares
$14.94
$12.34
Contineum Therapeutics
Contineum Therapeutics CTNM
Chief Scientific Officer
Holding Value $1.97M 160,000 shares
Last Trade
Jan 30, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$2.37M 166,500 shares
$14.26
$12.34
Contineum Therapeutics
Contineum Therapeutics CTNM
Chief Scientific Officer
Holding Value $1.98M 160,722 shares
Last Trade
Jan 05, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$43.5k 4,170 shares
$10.44
$12.34
Contineum Therapeutics
Contineum Therapeutics CTNM
Chief Scientific Officer
Holding Value $2.03M 164,392 shares
Last Trade
Dec 23, 2025 Sale (Open Market)Shares sold on the open market or in a private sale.
$51k 4,170 shares
$12.23
$12.34
Contineum Therapeutics
Contineum Therapeutics CTNM
Chief Scientific Officer
Holding Value $1.36M 110,000 shares
Last Trade
Jan 31, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.11M 113,700 shares
$9.79
$12.34

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up